Vitaspring Biomedical Co. Ltd.
VSBC· OTC
VSBCVitaspring Biomedical Co. Ltd.
Quarterly figures for Vitaspring Biomedical Co. Ltd., with source filings when available.
31 quarters. Apr 30, 2017 to Jul 31, 2026. USD.
Vitaspring Biomedical Co. Ltd. has filed its 10-Q within 45 to 53 days of period end across its last 8 quarters. The 10-K runs 73 to 137 days.
Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2027 | |||||||||
| Q2 2027 | Jul 31, 2026 | — | Sep 17, 2026 | 48 d | 10-Q | $0.00 | — | $0.00 | |
| Q1 2027 | Apr 30, 2026 | — | Jun 17, 2026 | 48 d | 10-Q | $0.00 | — | $0.00 | |
| FY 2026 | |||||||||
| Q4 2026derived | Jan 31, 2026 | — | Jun 17, 2026 | 137 d | 10-K | $0.00 | — | — | |
| Q3 2026 | Oct 31, 2025 | — | Jun 17, 2026 | ||||||
| FY 2025 | |||||||||
| Q4 2025derived | Jan 31, 2025 | — | Jun 8, 2026 | 493 d | 10-K | $0.00 | — | — | |
| Q3 2025 | Oct 31, 2024 | — | May 6, 2026 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Jan 31, 2024 | — | Mar 12, 2026 | 771 d | 10-K | $0.00 | — | — | |
| Q3 2024 | Oct 31, 2023 | — | Jan 30, 2026 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Jan 31, 2023 | — | Dec 1, 2025 | 1035 d | 10-K | — | — | — | |
| Q3 2023 | Oct 31, 2022 | — | Dec 21, 2022 | 51 d | 10-Q | ||||
| FY 2020 | |||||||||
| Q1 2020 | Apr 30, 2020 | — | Jun 19, 2020 | 50 d | 10-Q | $0.00 | −100.0% | $0.00 | |
| FY 2019 | |||||||||
| Q4 2019derived | Jan 31, 2020 | — | Jun 9, 2020 | 130 d | 10-K | — | — | — | |
| Q3 2019 | Oct 31, 2019 | — | Dec 12, 2019 | 42 d | 10-Q | ||||
| FY 2018 | |||||||||
| Q4 2018derived | Jan 31, 2019 | — | Apr 26, 2019 | 85 d | 10-K | $2.66K | — | — | |
| Q3 2018 | Oct 31, 2018 | — | Nov 21, 2018 | ||||||
| FY 2017 | |||||||||
| Q4 2017derived | Jan 31, 2018 | — | May 16, 2018 | 105 d | 10-K | — | — | — | |
| Q3 2017 | Oct 31, 2017 | — | Nov 15, 2017 | 15 d | 10-Q | ||||
| 229 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2026 | Jul 31, 2025 | — | Jun 17, 2026 | 321 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2026 | Apr 30, 2025 | — | Jun 15, 2026 | 411 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 552 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2025 | Jul 31, 2024 | — | Apr 22, 2026 | 630 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2025 | Apr 30, 2024 | — | Apr 2, 2026 | 702 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 822 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2024 | Jul 31, 2023 | — | Jan 23, 2026 | 907 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2024 | Apr 30, 2023 | — | Jan 13, 2026 | 989 d | 10-Q | $0.00 | −100.0% | $0.00 |
|---|
| $0.00 |
| — |
| $0.00 |
| Q2 2023 | Jul 31, 2022 | — | Sep 15, 2022 | 46 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2023 | Apr 30, 2022 | — | Jun 15, 2022 | 46 d | 10-Q | $1.49M | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2019 | Jul 31, 2019 | — | Aug 27, 2019 | 27 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2019 | Apr 30, 2019 | — | Jun 3, 2019 | 34 d | 10-Q | $7.22K | −42.0% | $0.00 |
|---|
| 21 d |
| 10-Q |
| $75.00 |
| −97.8% |
| $0.00 |
| Q2 2018 | Jul 31, 2018 | — | Aug 15, 2018 | 15 d | 10-Q | $2.00K | −60.0% | $0.00 |
|---|
| Q1 2018 | Apr 30, 2018 | — | Jun 4, 2018 | 35 d | 10-Q | $12.45K | +103.4% | $0.00 |
|---|
| $3.46K |
| — |
| $0.00 |
| Q2 2017 | Jul 31, 2017 | — | Aug 16, 2017 | 16 d | 10-Q | $5.00K | — | $0.00 |
|---|
| Q1 2017 | Apr 30, 2017 | — | Jun 8, 2017 | 39 d | 10-Q | $6.12K | — | $0.00 |
|---|
